Recruiting Neurofibromatosis Studies in Palo Alto
About Neurofibromatosis Clinical Trials in Palo Alto
Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerve tissue. NF1 is the most common type, causing skin changes and bone deformities. Treatment includes monitoring, surgery for problematic tumors, and MEK inhibitors for plexiform neurofibromas.
There are currently 2 neurofibromatosis clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 225 participants. Research is being sponsored by University of Alabama at Birmingham, Healx Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neurofibromatosis Clinical Trials in Palo Alto — FAQ
Are there neurofibromatosis clinical trials in Palo Alto?
Yes, there are 2 neurofibromatosis clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What neurofibromatosis treatments are being tested?
The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for neurofibromatosis.
Data updated October 16, 2026 from ClinicalTrials.gov